Lebedeva M V, Balkarov I M, Lukicheva T I, Men'shikov V V, Mukhin N A, Varshavskĭ V A, Proskurneva E P, Aleksandrovaskaia T N
Ter Arkh. 1998;70(4):48-54.
Development of the approaches to detection of hyperuricosuric stage of purin metabolism derangement and specification of methods for early diagnosis of urate damage to the kidney.
The study included 115 young subjects whose parents suffer from gout with renal involvement or isolated urate nephropathy. Each patient was examined clinically with evaluation of family history for gout risk factors. Three times for 9 months measurements were made of uricemia and uricosuria, microalbuminuria and activity of tubular enzyme NAG.
45 (39.1%) patients had neither disturbances of purin metabolism nor renal affection. 70 (60.9%) patients had hyperuricosuria. In 23 (32.9%) of them microalbuminuria increased to > 20 mg/day, NAG activity to 5 u/l. Chronic tubulointerstitial nephritis was diagnosed in 17 (73.9%) patients. Six patients (26.1%) developed asymptomatic affection of the kidneys. The rest 47 patients had normal levels of microalbuminuria and NAG. There were 3 cases of hyperuricemia with microalbuminuria rising to 160-200 mg/day and further development of urinary syndrome. Hyperuricemia in them was registered at microalbuminuria higher that 160 mg/day.
Microalbuminuria higher than 20 mg/day and NAG activity higher than 5 u/day are important diagnostic indicators of renal affection in hyperuricosuria including asymptomatic one. Microalbuminuria above 160 mg/day gives grounds to discuss the role of morphological changes prior to proteinuria.
开发嘌呤代谢紊乱高尿酸尿阶段的检测方法,并明确早期诊断尿酸对肾脏损害的方法。
该研究纳入了115名年轻受试者,其父母患有痛风伴肾脏受累或孤立性尿酸盐肾病。对每位患者进行临床检查,并评估家族史中的痛风危险因素。在9个月内对血尿酸、尿尿酸、微量白蛋白尿和肾小管酶NAG活性进行了三次测量。
45名(39.1%)患者既无嘌呤代谢紊乱也无肾脏病变。70名(60.9%)患者有高尿酸尿。其中23名(32.9%)患者微量白蛋白尿增加至>20mg/天,NAG活性增加至5u/l。17名(73.9%)患者被诊断为慢性肾小管间质性肾炎。6名患者(26.1%)出现无症状性肾脏病变。其余47名患者微量白蛋白尿和NAG水平正常。有3例高尿酸血症患者,微量白蛋白尿升至160 - 200mg/天,并进一步发展为泌尿系统综合征。他们的高尿酸血症在微量白蛋白尿高于160mg/天时被记录到。
微量白蛋白尿高于20mg/天和NAG活性高于5u/天是高尿酸尿包括无症状性高尿酸尿时肾脏受累的重要诊断指标。微量白蛋白尿高于160mg/天为讨论蛋白尿前形态学改变的作用提供了依据。